Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Perceptions of Daratumumab Therapy

Conference Correspondent  - Hematologic Cancers, Conference Correspondent, ASH
Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief
Beth Faiman sees daratumumab as a game changer for patients with multiple myeloma.
Related Items
From the Editor - TON August 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in From the Editors
From the Editor - TON June 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - June 2019, Vol 12, No 3 published on June 17, 2019 in From the Editors
From the Editor - TON April 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - April 2019, Vol 12, No 2 published on April 22, 2019 in From the Editors
From the Editor - TON February 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - February 2019, Vol 12, No 1 published on March 1, 2019 in From the Editors
From the Editor - TON November 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2018, Vol 11, No 5 published on November 28, 2018 in From the Editors
From the Editor - TON July 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in From the Editors
Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
The Importance of Compassion: Perspective From a Lifelong Patient
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Addressing the Second Victim Phenomenon
Charles Bankhead
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Last modified: December 5, 2017